Jodi McCaffrey, MA, FACHE

The findings suggest the retina may be a possible biomarker for cognitive decline.

Nightly LBNP may be an effective countermeasure against early markers of ocular remodeling associated with space-associated neuro-ocular syndrome.

The decision to offer adjuvant chemotherapy and radiotherapy depends on the definition of “high-risk” retinoblastoma, but this definition varies by practice.

A uniform approach could help control pain in this densely innervated region of the body.

Researchers advocate for implementing steroid therapy on an individual basis, not as routine.

Researchers evaluated the brain health assessment scores of patients who received treatments for AMD.

Researchers explore the neurodevelopmental outcomes of bevacizumab utilized in newborn patients with retinopathy of prematurity.